The science to cure deafness has existed for years. They just proved it on 10 patients. 10 out of 10 could hear after a SINGLE injection. So why haven't you heard about this? Researchers injected a modified virus into the cochlea — carrying a working copy of the OTOF gene. Without OTOF: your ear hears everything. Your brain receives nothing. One injection. Fixed. Now here's where it gets uncomfortable: • Cochlear implants: $30K–$100K per patient • Hearing aids: up to $7,000 • Global hearing industry: $9 BILLION per year All of it recurring. Because deafness has never been cured — just managed. In 2018, Goldman Sachs sent a note to investors warning them about gene therapy companies. The exact words: "Curing patients is not a sustainable business model." This same platform already cured a form of blindness in 2017. Cured spinal muscular atrophy in babies in 2019. There are 10,000+ known single-gene disorders. The platform exists. The proof is 10 out of 10. The question was never could they fix it. It's whether fixing it was good for business. Which single-gene disorder do you think gets cured next — and which industry fights it hard(CyrilXBT)